East Lansing, Michigan, United States | Fund Name | Location |
| Addition | New York, New York, United States |
| Baron Capital | New York, New York, United States |
| BioFrontier Partners | Japan, Tokyo |
| Canguro Inversiones | - |
| Ch-gemstone capital | Beijing, Beijing, China |
| Chimera Securities | New York, New York, United States |
| CLS Holdings | England, London, United Kingdom |
| Drumbeat Ventures | - |
| edX | Cambridge, Massachusetts, United States |
| Enterprise Reform and Development Equity Investment Fund | - |
| Jingpai | China, Huangshi, Hubei |
| Lionsgate | California, Santa Monica, United States |
| Niagara Angel Network | Canada, Ontario, Toronto |
| Reneo Capital Management | New York, New York, United States |
| Shangdong Konggu | China, Guangdong, Guangzhou |
| Swanhill Capital | - |
| Tallwood Venture Capital | California, Menlo Park, United States |
| University of Chicago | Chicago, Illinois, United States |
| Yeoman's Capital | Austin, Texas, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Opnr | 25 May 2023 | Detroit, Michigan, United States | |||
TiiCKER | $5M | 19 Apr 2023 | Detroit, Michigan, United States | ||
Kall Morris | 07 Apr 2023 | - | |||
Enspired Solutions | 06 Apr 2023 | - | |||
MagPlasma, Inc | 16 Mar 2023 | - | |||
CavGene Therapeutics | 14 Feb 2023 | - | |||
Iaso Therapeutics | $1M | 03 Jan 2023 | East Lansing, Michigan, United States | ||
Adastec Corp. | 28 Dec 2022 | San Francisco, California, United States | |||
Advertent Biotherapeutics | 14 Dec 2022 | - |
– TiiCKER is a Detroit, MI-based retail investor engagement, marketing and stock perks startup.
– The company closed a $2m pre-seed funding.
– Backers included Red Cedar Ventures and several YPO (Young Presidents’ Organization) members.
– The new investment will be used to develop software for the company’s planned feature additions, sales and marketing expansion, as well as client engagement and onboarding talent.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Opnr | 25 May 2023 | Detroit, Michigan, United States | |||
TiiCKER | $5M | 19 Apr 2023 | Detroit, Michigan, United States | ||
Kall Morris | 07 Apr 2023 | - | |||
Enspired Solutions | 06 Apr 2023 | - | |||
MagPlasma, Inc | 16 Mar 2023 | - | |||
CavGene Therapeutics | 14 Feb 2023 | - | |||
Iaso Therapeutics | $1M | 03 Jan 2023 | East Lansing, Michigan, United States | ||
Adastec Corp. | 28 Dec 2022 | San Francisco, California, United States | |||
Advertent Biotherapeutics | 14 Dec 2022 | - |
